GC-MS based plasma metabolomics for identification of candidate biomarkers for hepatocellular carcinoma in Egyptian cohort

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Ranjbar, Mohammad R Nezami ^a   Luo, Yue ^a   DiPoto, Cristina ^a   Varghese, Rency S ^a   Ferrarini, Alessia ^a   Zhang, Chi ^a   Sarhan, Naglaa I ^b   Soliman, Hanan ^b   Tadesse, Mahlet G ^c   Ziada, Dina H ^b   Roy, Rabindra ^a   Ressom, Habtom W ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b TANTA UNIVERSITY   (Egypt)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ALPHA TOCOPHEROL; CHOLESTEROL; CITRIC ACID; GLUTAMIC ACID; ISOLEUCINE; LACTIC ACID; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; TUMOR MARKER; VALINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CACHEXIA; COHORT ANALYSIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EGYPTIAN; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; TIME OF FLIGHT MASS SPECTROMETRY; TUMOR GROWTH; UPREGULATION; BLOOD; EGYPT; LIVER TUMOR; MASS FRAGMENTOGRAPHY; METABOLISM; MIDDLE AGED; PROCEDURES;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; EGYPT; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIVER NEOPLASMS; MALE; METABOLOMICS; MIDDLE AGED;

EID: 84931287980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127299     Document Type: Article

References (45)

1. Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, et al. Survival rate in patients with hepatocellular carcinoma: A retrospective analysis of 389 patients. Br J Cancer. 2005; 92: 1862-1868. doi: 6602590 [pii]. PMID: 15870713
2. Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status. J Hepatol. 2001; 34: 570-575. PMID: 11394657
3. Gupta S, Bent S, Kohlwes J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med. 2003; 139: 46-50. PMID: 12834318
4. Yoshihiko T, Nishiumi S, Minami A, Kawano Y, Hoshi N, Azuma T, et al. Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis. Arch Biochem Biophys. 2014; 555-556:55-65. doi: 10.1016/j.abb.2014.05.012 PMID: 24943258
5. Fitian AI, Nelson DR, Liu C, Xu Y, Ararat M, Cabrera R. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS. Liver International. 2014.
6. Beyoglu D, Imbeaud S, Maurhofer O, Bioulac-Sage P, Zucman-Rossi J, Dufour JF, et al. Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology. 2013. doi: 10.1002/hep.26350; 10.1002/hep.26350.
7. Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, et al. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Molecular & Cellular Proteomics. 2011; 10: M110.004945.
8. Wang B, Chen D, Chen Y, Hu Z, Cao M, Xie Q, et al. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry. J. Proteome Res. 2012; 11: 1217-1227. doi: 10.1021/pr2009252 PMID: 22200553
9. Tan Y, Yin P, Tang L, Xing W, Huang Q, Cao D, et al. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: Potential biomarkers effective for small hepatocellular carcinoma diagnosis. Molecular & Cellular Proteomics. 2012; 11(2):M111.010694.
10. Patterson AD, Maurhofer O, Beyoglu D, Lanz C, Krausz KW, Pabst T, et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Research. 2011; 71: 6590-6600. doi: 10.1158/0008-5472.CAN-11-0885 PMID: 21900402
11. Chen J, Wang W, Lv S, Yin P, Zhao X, Lu X, et al. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Analytica Chimica Acta. 2009; 650: 3-9. doi: 10.1016/j.aca.2009.03.039 PMID: 19720165
12. Yang J, Zhao X, Liu X, Wang C, Gao P, Wang J, et al. High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res. 2006; 5: 554-561. doi: 10.1021/pr050364w PMID: 16512670
13. Cao H, Huang H, Xu W, Chen D, Yu J, Li J, et al. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry. Analytica Chimica Acta. 2011; 691: 68-75. doi: 10.1016/j.aca.2011.02.038 PMID: 21458633
14. Huang Q, Tan Y, Yin P, Ye G, Gao P, Lu X, et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 2013; 73: 4992-5002. doi: 10.1158/0008-5472.CAN-13-0308 PMID: 23824744
15. Liu Y, Hong Z, Tan G, Dong X, Yang G, Zhao L, et al. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis. Int J Cancer. 2014; 135: 658-668. doi: 10.1002/ijc.28706 PMID: 24382646
16. Xiao JF, Zhao Y, Varghese RS, Zhou B, Di Poto C, Zhang L, et al. Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis. Cancer Epidemiol Biomarkers Prev. 2014; 23: 64-72. doi: 10.1158/1055-9965.EPI-13-0327 PMID: 24186894
17. Ressom HW, Xiao JF, Tuli L, Varghese RS, Zhou B, Tsai T, et al. Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Analytica Chimica Acta. 2012; 743: 90-100. doi: 10.1016/j.aca.2012.07.013 PMID: 22882828
18. Xiao JF, Varghese RS, Zhou B, Nezami Ranjbar MR, Zhao Y, Tsai TH, et al. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in egyptian cohort. J Proteome Res. 2012; 11: 5914-5923. doi: 10.1021/pr300673x PMID: 23078175
19. Xue R, Dong L, Zhang S, Deng C, Liu T, Wang J, et al. Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2008; 22: 1181-1186. doi: 10.1002/rcm.3466 PMID: 18350562
20. Qin T, Liu H, Song Q, Song G, Wang HZ, Pan YY, et al. The screening of volatile markers for hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2247-2253. doi: 10.1158/1055-9965. EPI-10-0302 PMID: 20826831
21. Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, et al. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology. 2013; 144: 1066-1075.e1. doi: 10.1053/j.gastro.2013.01.054 PMID: 23376425
22. Batra SK, Fong MY, McDunn J, Kakar SS. Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS ONE. 2011; 6: e19963. doi: 10.1371/journal.pone.0019963 PMID: 21625518
23. Ye G, Zhu B, Yao Z, Yin P, Lu X, Kong H, et al. Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry. J Proteome Res. 2012; 11: 4361-4372. doi: 10.1021/pr300502v PMID: 22768978
24. Xue R, Lin Z, Deng C, Dong L, Liu T, Wang J, et al. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2008; 22: 3061-3068. doi: 10.1002/rcm.3708 PMID: 18767022
25. Xiao JF, Varghese RS, Zhou B, Nezami Ranjbar MR, Zhao Y, Tsai T, et al. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in egyptian cohort. Journal of proteome research. 2012; 11: 5914-5923. doi: 10.1021/pr300673x PMID: 23078175
26. Fiehn O, Kind T. Metabolite profiling in blood plasma. Methods Mol Biol. 2007; 358: 3-17. doi: 1-59745-244-0:3 [pii]. PMID: 17035677
27. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011; 6: 1060-1083. doi: 10.1038/nprot.2011.335 PMID: 21720319
28. Stein SE. An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data. J Am Soc Mass Spectrom. 1999; 10: 770-781.
29. Hiller K, Hangebrauk J, Jäger C, Spura J, Schreiber K, Schomburg D. MetaboliteDetector: Comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Anal Chem. 2009; 81: 3429-3439. doi: 10.1021/ac802689c PMID: 19358599
30. Stein SE. Estimating probabilities of correct identification from results of mass spectral library searches. J Am Soc Mass Spectrom. 1994; 5: 316-323. doi: 10.1016/1044-0305(94)85022-4 PMID: 24222569
31. Kinoshita H, Okabe H, Beppu T, Chikamoto A, Hayashi H, Imai K, et al. Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma. Oncol Rep. 2013; 29: 685-689. doi: 10.3892/or.2012.2162 PMID: 23229496
32. O'Connell TM. The complex role of branched chain amino acids in diabetes and cancer. Metabolites. 2013; 3: 931-945. doi: 10.3390/metabo3040931 PMID: 24958258
33. Liu KA, Lashinger LM, Rasmussen AJ, Hursting SD. Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice. Cancer Metab. 2014; 2: 6-3002-2-6. doi: 10.1186/2049-3002-2-6
34. Dodd KM, Tee AR. Leucine and mTORC1: A complex relationship. Am J Physiol Endocrinol Metab. 2012; 302: E1329-42. doi: 10.1152/ajpendo.00525.2011 PMID: 22354780
35. HUEPER WC. Are sugars carcinogens?an experimental study. Cancer Res. 1965; 25: 440-443. PMID: 14297479
36. Girniene J, Tatibouet A, Sackus A, Yang J, Holman GD, Rollin P. Inhibition of the D-fructose transporter protein GLUT5 by fused-ring glyco-1,3-oxazolidin-2-thiones and-oxazolidin-2-ones. Carbohydr Res. 2003; 338: 711-719. doi: S0008621503000077 [pii]. PMID: 12668090
37. Bauer DE, Hatzivassiliou G, Zhao F, Andreadis C, Thompson CB. ATP citrate lyase is an important component of cell growth and transformation. Oncogene. 2005; 24: 6314-6322. doi: 1208773 [pii]. PMID: 16007201
38. Munoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: Current perspectives and future directions. Cell Death Dis. 2012; 3: e248. doi: 10.1038/cddis.2011.123 PMID: 22237205
39. Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007; 109: 3812-3819. doi: blood-2006-07-035972 [pii]. PMID: 17255361
40. Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev. 2007; 26: 299-310. doi: 10.1007/s10555-007-9064-0 PMID: 17415526
41. Adam RM, Mukhopadhyay NK, Kim J, Di Vizio D, Cinar B, Boucher K, et al. Cholesterol sensitivity of endogenous and myristoylated akt. Cancer Res. 2007; 67: 6238-6246. doi: 67/13/6238 [pii]. PMID: 17616681
42. Alda M, Shao L, Wang JF, Lopez de Lara C, Jaitovich-Groisman I, Lebel V, et al. Alterations in phosphorylated cAMP response element-binding protein (pCREB) signaling: An endophenotype of lithium-responsive bipolar disorder? Bipolar Disord. 2013; 15: 824-831. doi: 10.1111/bdi.12131 PMID: 24238631
43. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A. 2005; 102: 4459-4464. doi: 0501076102 [pii]. PMID: 15753290
44. Yu L, Guo X, Zhang P, Qi R, Li Z, Zhang S. Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinoma. Onco Targets Ther. 2014; 7: 873-879. doi: 10.2147/OTT.S63594 PMID: 24926200
45. Kovach SJ, Price JA, Shaw CM, Theodorakis NG, McKillop IH. Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma. J Cell Physiol. 2006; 206: 411-419. doi: 10.1002/jcp.20474 PMID: 16110470